As per DelveInsight, the Liver Cancer Market is anticipated to evolve immensely in the coming years owing to the rise in the incidence of the population in the 7MM, the rise in healthcare spending across the world, and the launch of new therapies in the market. Some of the key players, such as CStone Pharmaceuticals, SOTIO Biotech, Akeso Biopharma, among others, are actively working to develop new therapies for the treatment of Liver Cancer. The emerging therapies hold the potential to transform the treatment scenario in the upcoming years.
DelveInsight’s “Liver Cancer Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Liver Cancer Market Size and Share in the seven major markets (7MM) (i.e., the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom and Japan).
The market report covers emerging drugs, treatment practices, market share of individual Liver Cancer therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current Liver Cancer treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of opportunities and assess the underlying potential of the market.
Liver Cancer: An Overview
Liver cancer is a type of cancer that starts in the liver. It is the sixth most commonly diagnosed cancer worldwide and the third most common cause of cancer death. Hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (iCCA) are the two main histological subtypes of primary liver cancer. They differ in their aetiology and epidemiology.
Globally, the main risk factors for HCC are infection with hepatitis B or hepatitis C viruses. HCC can also be caused by heavy alcohol use, obesity, diabetes, and ingestion of aflatoxins. iCCA develops in the bile ducts within the liver. Risk factors for iCCA include primary sclerosing cholangitis, Caroli’s disease and hepatolithiasis.
Liver cancer subtypes that are less common include hepatoblastoma – a rare childhood cancer – and angiosarcoma which has been linked to historic occupational exposure to vinyl chloride, among other risk factors. Liver cancer may also spread to nearby lymph nodes and/or to distant sites within the body. Liver cancer does not often metastasize, but when it does, it is most likely to spread to the lungs and bones. These cancers are widespread, they cannot be removed with surgery
Liver Cancer Market Key Facts
- According to the Global Cancer Observatory, in the 7MM the ASR incident rate of liver cancer is 7.4/100,000 which is estimated to be around 135,530 new cases in 2020 and the ASR mortality rate of liver cancer is 4.8/100,000 which is estimated to be around 100,790 number of deaths in 2020.
- According to the Global cancer observatory, in Japan, the ASR incident rate of liver cancer is 10.4/100,000 which is estimated to be around 45,660 new cases diagnosed in 2020 and the ASR mortality rate of liver cancer is 4.8/100,000 which is estimated to be around 28,155 number of deaths in 2020.
- According to a study done by Siegel et al. 2020, on liver cancer rates used by the National Cancer Institute, there were 42,810 new cases of liver cancer in the United States of America in 2020. Of this number, 30,170 were males and 12,640 were females.
- According to the latest WHO data published in 2020 Liver Cancer Deaths in Germany reached 8,057 or 1.15% of total deaths.
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted market size by analyzing the impact of current and emerging Liver Cancer therapies in the market. It also provides a detailed assessment of the Liver Cancer market drivers & barriers, unmet needs, and emerging technologies.
The report gives complete detail of the market trend for each marketed Liver Cancer drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MOA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.
Discover How Liver Cancer Market Will Grow by 2032 @ Liver Cancer Market Outlook and Forecast
The epidemiology section covers detailed insights into the historical, and current Liver Cancer patient pool and forecasted epidemiology trends for every seven major countries (7MM) from 2019 to 2032.
The Report Covers the Liver Cancer Epidemiology Segmented as –
- Incident Cases of Liver Cancer in the 7MM [2019–2032]
- Gender-specific Diagnosed Incidence of Liver Cancer in the 7MM [2019–2032]
- Stage-specific Diagnosed Incidence of Liver Cancer in the 7MM [2019–2032]
- Treated cases of Liver Cancer in the 7MM [2019–2032]
Get Key Insights Into the Evolving Epidemiology Trends @ Liver Cancer Epidemiology Forecast
The drugs’ uptake section focuses on the rate of uptake of the potential drugs recently launched in the Liver Cancer market or expected to be launched during the study period. The analysis covers the market share of Liver Cancer drugs, patient uptake by therapies, and sales of each drug.
The report’s drugs uptake section helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs. It allows the comparison of the drugs based on market share and size, which again will be helpful in investigating factors important in understanding the market dynamics and in making financial and regulatory decisions.
The report also covers the Liver Cancer Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Explore More About Ongoing Pipeline Development Activities @ Liver Cancer Therapeutics Pipeline Assessment
Several major pharma and biotech companies are developing therapies Liver Cancer. Currently, Polaris Group is leading the therapeutics market with its Liver Cancer drug candidates in the most advanced stage of clinical development.
Leading Companies in the Liver Cancer Therapeutics Market Include
- Shanghai Henlius Biotech
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Jiangsu Hengrui Medicine
- Glaxo SmithKline
- ZAI Lab
- Beijing Immunochina Medical Science and Technology
- MiNA Therapeutics
- Abbisko Therapeutics
- Medivir AB
- Eureka Therapeutics
- Celsion Corporation
- H3 Biomedicine
- TriSalus Life Sciences
- Celldex Therapeutics
- Megapro Biomedical Company
- Polaris Group
And Many Others
Emerging and Marketed Liver Cancer Therapies Covered in the Report Include
- SRF388: Surface Oncology
- MTL-CEBPA: MiNA Therapeutics
- APX3330: Ocuphire Pharma
- Fostroxacitabine bralpamide: Medivir
- CDX-527: Celldex Therapeutics
- CYRAMZA (ramucirumabis): Eli Lilly
- KEYTRUDA (pembrolizumab): Merck
- TECENTRIQ (atezolizumab): Genetech
- JEMPERLI (dostarlimab): GlaxoSmithKline
- OPDIVO (nivolumab): Bristol-Myers Squibb
- YERVOY (ipilimumab): Bristol-Myers Squibb
And Many More
Learn More About the Evolving Therapeutics Outlook @ Liver Cancer Emerging Therapies and Key Companies
Table of Content (TOC)
- Key Insights
- Executive Summary
- Liver Cancer Competitive Intelligence Analysis
- Liver Cancer Market Overview at a Glance
- Liver Cancer Background and Overview
- Liver Cancer Patient Journey
- Liver Cancer Epidemiology and Patient Population
- Liver Cancer Treatment Algorithm, Current Treatment, and Medical Practices
- Liver Cancer Unmet Needs
- Key Endpoints of Liver Cancer Treatment
- Liver Cancer Marketed Products
- Liver Cancer Emerging Therapies
- Liver Cancer Seven Major Market Analysis
- Attribute Analysis
- Liver Cancer Market Outlook (7 major markets)
- Liver Cancer Access and Reimbursement Overview
- KOL Views on the Liver Cancer Market.
- Liver Cancer Market Drivers
- Liver Cancer Market Barriers
- DelveInsight Capabilities
*The table of contents is not exhaustive; the final content may vary.
Download the Sample PDF to Get Detailed Insights About the Report’s Offerings @ Liver Cancer Market Forecast
Related Report by DelveInsight:
“Liver Failure Epidemiology Forecast 2032” report delivers an in-depth understanding of the disease, and historical & forecasted Liver Failure epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
“Liver Failure Pipeline Insight, 2023,” report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in the Liver Failure pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products.
“Hepatic Cirrhosis Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Hepatic Cirrhosis market size, share, trends, and growth analysis in the seven major markets (i.e. the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan. Some of the key companies such as NGM Biopharmaceuticals Inc, Conatus Pharmaceuticals Inc, Grifols Therapeutics LLC, Norgine, Mallinckrodt, Intercept Pharmaceuticals, and others are actively working in the market.
“Hepatocellular Carcinoma Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Hepatocellular Carcinoma market size, share, trends, and growth analysis in the seven major markets (i.e. the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan. Key players such as H3 Biomedicine, Genoscience Pharma, Kymab, Sanofi, Exelixis and various others are involved in developing therapies for Hepatocellular Carcinoma.
“Acute On Chronic Liver Failure (ACLF) Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Acute On Chronic Liver Failure market size, share, trends, and growth analysis in the seven major markets (i.e. the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan. Some of the Acute On Chronic Liver Failure companies working in the market are Grifols Therapeutics, Promethera Biosciences, GENFIT, Akaza Bioscience, RHEACELL, Versantis, Martin Pharmaceuticals, Cipla, and others.
Other Trending Healthcare Reports by DelveInsight:
Lhon Market | Fibrocystic Breast Condiion Market | Chronic Gout Market | Acral Lentiginous Melanoma Market | Concussions Market Size | Familial Primary Pulmonary Hypertension Market | Hpv-induced Cancers Market | Malt Lymphoma Market | Polycythemia Market | Ventilator Market | X Linked Hypophosphatemia Market | Wound Closure Devices Market | Vitamin A Deficiency Market | Vertigo Market | Vascular Access Devices Market | Upper Limb Hypertonia Market | Triple Negative Breast Cancer Market | Thymic Carcinoma Market | Thrombocytopenia Market | Surgical Site Infection Ssi Market | Spasticity Market | Severe Hypoglycemia Market | Scleroderma Market | Radiation Toxicity Market | Pulse Oximeters Market | Pruritus Market | Prader-willi Syndrome Market | Post Traumatic Stress Disorder Market | Pediatric Obesity Market | Palmar Hyperhidrosis Market Size | Pain Management Devices Market | Osteochondromas Market | Osteoarthritis Market | Oral Mucositis Om Market | Opioid Induced Constipation Market | Ophthalmic Imaging Equipment Market | Onycholysis Market | Ncfb Market | Neurovascular Devices Market | Neurostimulation Devices Market | Neuromodulation Devices Market | Neurofibromatosis 2 Market | Neuroblastoma Market | Necrotizing Enterocolitis Market | Metachromatic Leukodystrophy Market Research Report | Kidney Transplant Rejection Market | Juvenile Rheumatoid Arthritis Market | Implantable Infusion Pumps Market | Immunologic Deficiency Syndrome Market | Image Guided Surgery Devices Market | Hypothalamic Obesity Market | Hypoparathyroidism Market | Hyperuricemia Market | Hyperhidrosis Market |Hereditary Spastic Paraplegias Market | Hemophilia B Market | Hemodynamic Monitoring Systems Market | Hearing Implants Market | Foot And Ankle Devices Market | Epilepsy Market | Global Electrophysiology Devices Market | Ehlers-danlos Syndrome Market | Dlbcl Market | Diffuse Large B-cell Lymphoma Market | Dermal Mycosis Market | Dermal Erythema Market | Defibrillators Market | Deep Vein Thrombosis Market | Corneal Ulcer Market | Contusion Market | Contraceptive Devices Market | Continuous Renal Replacement Therapy Machines Market | Hyperinsulinemic Hypoglycemia Market | Cluster Headache Market | Chronic Pruritus Market | Chronic Progressive Multiple Sclerosis Market | Chronic Plaque Psoriasis Market | Chronic Lymphocytic Leukemia Market | Chronic Insomnia Market | Chronic Inflammtory Demyelinating Polyneuropathy Market | Hepatitis B Virus Market | Chronic Bronchitis Market | Chondrosarcoma Market | Chemotherapy Induced Anemia Market | Cerebral Vein Thrombosis Market | Cellulitis Market | Catheter-related Bloodstream Infections Market | Car T Therapy For Acute Lymphoblastic Leukemia All Market | Cardiopulmonary Bypass Equipment Market | Cardiac Biomarkers Testing Devices Market | Carcinoid Tumor Market | Capnography Device Market | Calciphylaxis Market | Bunion Market | Bronchial Spasm Market | Brain/cranial Implants Market | Bradycardia Treatment Devices Market | Blood Glucose Monitoring Systems Market | Blood Gas And Electrolyte Analyzers Market | Biliary Tract Carcinoma Market | Bartonellosis Market | Atopic Keratoconjunctivitis Akc Market | Eczema Market | Atherectomy Devices Market | Aspergillosis Market | Ashermans Syndrome Market | Arthroscopic Shavers Market | Arteriovenous Fistula Market | Aortic Stenosis Market | Aortic Aneurysm Stent Grafts Market | Antiphospholipid Syndrome Aps Market | Anterior Cruciate Ligament Injuries Market | Anovulation Market | Anemia In Ckd Market | Alzheimer Disease Market | Alopecia Aerata Market | Alopecia Areata Market | Alkaptonuria Market | Aids Related Kaposi’s Sarcoma Market | Age-related Macular Degeneration Market | Advanced Renal Cell Carcinoma Market | Advanced Cancer Pain Management Market | Adrenal Crisis Market | Adrenal Insufficiency Market | Adrenal Cortex Neoplasms Market | Acute Pulmonary Embolism Market | Acute Pharyngitis Market | Acute Pain Market | Acute Coronary Syndrome Market | Absssi Market | Acute Agitation And Aggression Market | Acanthamoeba Keratitis Market | Waiha Market | Treatment Resistant Depression Market | Parkinson’s Disease Market | Osteosarcoma Market | Egfr Non-small Cell Lung Cancer Market | Beta Thalassemia Market | Acute On Liver Failure Market | Healthcare Subscription Models | Spinal Stenosis Market | Neuroprosthetics Market | Chronic Hepatitis Delta Virus Market | Pharma Competitive Intelligence | Competitive Intelligence Pharma | Biochips Market | Alpha Antitrypsin Market
Leverage the potential of consulting services to overcome the competition in the highly evolving and dynamic healthcare market with Healthcare Regulatory Analysis and Merger and Acquisitions in Healthcare Industry
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Manager (Marketing & Branding)